Page last updated: 2024-10-16

quinacrine and Ductus Arteriosus, Patent

quinacrine has been researched along with Ductus Arteriosus, Patent in 1 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, MM1
Putnam, TI1

Other Studies

1 other study available for quinacrine and Ductus Arteriosus, Patent

ArticleYear
An 18p21q translocation in a patient with presumptive "monosomy G".
    American journal of diseases of children (1960), 1972, Volume: 124, Issue:6

    Topics: Abnormalities, Multiple; Aneuploidy; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, 1

1972